Literature DB >> 9723436

Role of therapeutic drug monitoring of rapamycin.

B D Kahan1, K L Napoli.   

Abstract

Mesh:

Substances:

Year:  1998        PMID: 9723436     DOI: 10.1016/s0041-1345(98)00586-7

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  6 in total

1.  Switching from HPLC/UV to MEIA for whole blood sirolimus quantitation: comparison of methods.

Authors:  Luigi Alberto Pini; Daniela Gallesi; Daria Brovia; Alfio Bertolini; Diego Pinetti; Valentina Ruggieri; Stefania Pisa; Brunella Poppi; Carmela Nives Castellana
Journal:  J Clin Lab Anal       Date:  2006       Impact factor: 2.352

Review 2.  Immunosuppressive therapy for paediatric transplant patients: pharmacokinetic considerations.

Authors:  María del Mar Fernández De Gatta; Dolores Santos-Buelga; Alfonso Domínguez-Gil; María José García
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 3.  Use of sirolimus in solid organ transplantation.

Authors:  Joshua J Augustine; Kenneth A Bodziak; Donald E Hricik
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 4.  Sirolimus: the evidence for clinical pharmacokinetic monitoring.

Authors:  Sunita Bond Stenton; Nilufar Partovi; Mary H H Ensom
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

5.  Application of response surface methodology in development of sirolimus liposomes prepared by thin film hydration technique.

Authors:  Saeed Ghanbarzadeh; Hadi Valizadeh; Parvin Zakeri-Milani
Journal:  Bioimpacts       Date:  2013-04-30

6.  Synergistic cytoprotection by co-treatment with dexamethasone and rapamycin against proinflammatory cytokine-induced alveolar epithelial cell injury.

Authors:  Ken Kuwajima; Kyungho Chang; Ai Furuta; Masahiko Bougaki; Kanji Uchida; Shigehito Sawamura; Yoshitsugu Yamada
Journal:  J Intensive Care       Date:  2019-02-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.